hGH fragment raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-11 and is reviewed periodically as new material appears.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
This success was enough for him to take over the No. 1 ranking in late October. Before the end of the season, Zverev also represented Germany in the Junior Fed Cup, leading them to a fourth-place finish. His last tournament of the year was the Grade A Orange Bowl, where he was defeated by Stefan Kozlov in the semifinals. As the top-ranked junior at the end of the season, he was named the ITF Junior World Champion, becoming the youngest boys' champion since Donald Young in 2005. Zverev played just two tournaments in 2014, both in Australia in January. He won the singles events at both tournaments, the first of which came against Australian Omar Jasika at the Traralgon Junior International. At the Australian Open, he was able to defeat Kozlov, who was seeded second, to finish his junior career with a first major title. Junior Grand Slam results – Singles: Australian Open: W (2014) French Open: F (2013) Wimbledon: 3R (2013) US Open: SF (2013)
Around the end of the 16th century, increasing Cossack aggression strained relations between the Commonwealth and the Ottoman Empire. Cossacks had begun raiding Ottoman territories during the second part of the 16th century. The Polish government could not control them, but was held responsible as the men were nominally its subjects. In retaliation, Tatars living under Ottoman rule launched raids into the Commonwealth, mostly in the southeast territories. Cossack pirates responded by raiding wealthy trading port-cities in the heart of the Ottoman Empire, as these were just two days away by boat from the mouth of the Dnieper river. In 1615 and 1625, Cossacks razed suburbs of Constantinople, forcing the Ottoman Sultan to flee his palace. In 1637, the Zaporozhian Cossacks, joined by the Don Cossacks, captured the strategic Ottoman fortress of Azov, which guarded the Don. The Zaporizhian Cossacks became particularly strong in the first quarter of the 17th century under the leadership of hetman Petro Konashevych-Sahaidachny, who launched successful campaigns against the Tatars and Turks. Tsar Boris Godunov had incurred the hatred of Ukrainian Cossacks by ordering the Don Cossacks to drive away from the Don all the Ukrainian Cossacks fleeing the failed uprisings of the 1590s. This contributed to the Ukrainian Cossacks' willingness to fight against him. In 1604, 2,000 Zaporizhian Cossacks fought on the side of the Polish-Lithuanian Commonwealth and their proposal for the Tsar (Dmitri I), against the Muscovite army.
In 1913 the structure of sodium chloride was determined by William Henry Bragg and his son William Lawrence Bragg. This revealed that there were six equidistant nearest neighbours for each atom, demonstrating that the constituents were not arranged in molecules or finite aggregates, but instead as a network with long-range crystalline order. Many other inorganic compounds were also found to have similar structural features. These compounds were soon described as being constituted of ions rather than neutral atoms, but proof of this hypothesis was not found until the mid-1920s, when X-ray reflection experiments (which detect the density of electrons), were performed. Principal contributors to the development of a theoretical treatment of ionic crystal structures were Max Born, Fritz Haber, Alfred Landé, Erwin Madelung, Paul Peter Ewald, and Kazimierz Fajans. Born predicted crystal energies based on the assumption of ionic constituents, which showed good correspondence to thermochemical measurements, further supporting the assumption.
Sources: en.wikipedia.org
=== Legal status === MDMA is legally controlled in most of the world under the UN Convention on Psychotropic Substances and other international agreements, although exceptions exist for research and limited medical use. In general, the unlicensed use, sale or manufacture of MDMA are all criminal offences.
Leptin increases the production of leukocytes via actions on the hematopoietic niche, a pathway that is more active in sedentary mice and humans when compared to individuals who are physically active.
== Toxicity of UCM hydrocarbon components == There is compelling evidence that components within some UCMs are toxic to marine organisms. The clearance rate (also known as feeding feed) of mussels was reduced by 40% following exposure to a monoaromatic UCM derived from a Norwegian crude oil. The toxicity of monoaromatic UCM components was further evidenced by an elegant set of experiments using transplantations of clean and polluted mussels. Recent analysis by GC×GC-ToF-MS of UCMs extracted from the mussel tissues, has shown that they contain a vast array of both known and unknown compounds. The comparative analysis of UCMs extracted from mussels known to possess high, moderate and low Scope for Growth (SfG), a measure of the capacity for growth and reproduction, revealed that branched alkylbenzenes represented the largest structural class within the UCM of mussels with low SfG; also, branched isomers of alkyltetralins, alkylindanes and alkylindenes were prominent in the stressed mussels. Laboratory toxicity tests using both commercially available and specially synthesised compounds revealed that such branched alkylated structures were capable of producing the observed poor health of the mussels. The reversible effects observed in mussels following exposure to the UCM hydrocarbons identified to date are consistent with non-specific narcosis (also known as baseline) mode of action of toxicity. There is no evidence that toxic UCM components can biomagnify through the food chain.
Sources: en.wikipedia.org
(1990); "Copper-Catalyzed Amino Acid Condensation in Water - A Simple Possible Way of Prebiotic Peptide Formation"; Origins Life Evol. Biosphere 1990, 20(5), pp. 401–410. DOI: 10.1007/BF01808134. Schwendinger, M. G.; Rode, Bend M.(1998); "Possible Role of Copper and Sodium Chloride in Prebiotic Evolution of Peptides"; Anal. Sci. 1989, 5(4), pp. 411–414. DOI: 10.2116/analsci.5.411. Plankensteiner, Kristof; Reiner, Hannes; Schranz, Benjamin; Rode, Bernd M. (2004); "Prebiotic formation of amino acids in a neutral atmosphere by electric discharge"; Angew. Chem. Int. Ed. 2004, 43, pp. 1886–1888. [1] Fitz, Daniel; Reiner, Hannes; Rode, Bernd M. (2007); "Chemical evolution toward the origin of life"]; Pure Appl. Chem. 2007, 79(12), pp. 2101–2117. DOI: 10.1351/pac200779122101. Fitz, Daniel; Jakschitz, Thomas; Rode, Bernd M. (2011); "Salt-Induced Peptide Formation in Chemical Evolution: Building Blocks Before RNA - Potential of Peptide Splicing Reactions"; In: Origins of Life: The Primal Self-Organization, Egel, Richard; Lankenau, Dirk-Henner; Mulkidjanian, Armen Y. (Eds.), ISBN 978-3-642-21624-4, Springer, Heidelberg, Berlin 2011, pp. 109–127. Jakschitz, Thomas A.; Rode, Bernd M. (2012); "Chemical Evolution from simple inorganic compounds to chiral peptides"; Chem. Soc. Rev. 2012, 41(16), pp. 5484–5489. DOI: 10.1039/C2CS35073D. Rode, Bernd M.; Plankensteiner, Kristof (2013); "Prebiotic Peptides"; In: Handbook of Biologically Active Peptides, Second Edition, Abba J. Kastin (Eds.), ISBN 978-012-3850959, Elsevier, Amsterdam 2013, pp. 1899–1903.
=== Reusable cups === Starbucks has publicly committed to reducing waste by 50% by 2030. After successfully completing the campaign to provide the Reusable Cup in Vietnam in 2020, it held the same event in Korea in 2021. Along with a picture of throwing away a cleanly washed recycled PET bottle on Instagram, a hashtag designated by Starbucks was written and uploaded, and a reusable cup was provided instead of a disposable cup. In April 2013, Starbucks introduced reusable cups where customers would be able to bring their cup into any location and receive a small discount on their drink. When the COVID-19 pandemic first began in 2019, the company halted the use of personal cups due to concerns with the transferring of germs. In June 2021, the company reintroduced personal reusable cups with a contactless new method to eliminate shared touch points between customers and baristas. Starbucks is phasing out disposable cups in Korea entirely by 2025.
Iron uptake is tightly regulated by the human body, which has no regulated physiological means of excreting iron. Only small amounts of iron are lost daily due to mucosal and skin epithelial cell sloughing, so control of iron levels is primarily accomplished by regulating uptake. Regulation of iron uptake is impaired in some people as a result of a genetic defect that maps to the HLA-H gene region on chromosome 6 and leads to abnormally low levels of hepcidin, a key regulator of the entry of iron into the circulatory system in mammals. In these people, excessive iron intake can result in iron overload disorders, known medically as hemochromatosis. Many people have an undiagnosed genetic susceptibility to iron overload, and are not aware of a family history of the problem. For this reason, people should not take iron supplements unless they suffer from iron deficiency and have consulted a doctor. Hemochromatosis is estimated to be the cause of 0.3–0.8% of all metabolic diseases of Caucasians. Overdoses of ingested iron can cause excessive levels of free iron in the blood. High blood levels of free ferrous iron react with peroxides to produce highly reactive free radicals that can damage DNA, proteins, lipids, and other cellular components. Iron toxicity occurs when the cell contains free iron, which generally occurs when iron levels exceed the availability of transferrin to bind the iron. Damage to the cells of the gastrointestinal tract can also prevent them from regulating iron absorption, leading to further increases in blood levels.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.